Free Trial

Abingdon Health (ABDX) Competitors

Abingdon Health logo
GBX 6.17 -0.08 (-1.28%)
As of 03:23 AM Eastern

ABDX vs. YGEN, VRCI, GENI, GDR, AGL, PRM, IDHC, DMTR, LLAI, and LLA

Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include Yourgene Health (YGEN), Verici Dx (VRCI), GENinCode (GENI), genedrive (GDR), ANGLE (AGL), Proteome Sciences (PRM), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), LungLife AI (LLAI), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry.

Abingdon Health vs. Its Competitors

Abingdon Health (LON:ABDX) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

6.1% of Abingdon Health shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 10.4% of Abingdon Health shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Abingdon Health has a net margin of -20.72% compared to Yourgene Health's net margin of -27.55%. Yourgene Health's return on equity of -27.06% beat Abingdon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Abingdon Health-20.72% -62.56% -17.93%
Yourgene Health -27.55%-27.06%-6.71%

Abingdon Health has higher earnings, but lower revenue than Yourgene Health. Abingdon Health is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abingdon Health£6.82M1.75-£796.37K-£0.73-8.45
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A

Abingdon Health has a beta of 0.13, indicating that its share price is 87% less volatile than the S&P 500. Comparatively, Yourgene Health has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

In the previous week, Abingdon Health had 1 more articles in the media than Yourgene Health. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for Yourgene Health. Abingdon Health's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company Overall Sentiment
Abingdon Health Neutral
Yourgene Health Neutral

Summary

Yourgene Health beats Abingdon Health on 7 of the 11 factors compared between the two stocks.

Get Abingdon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABDX vs. The Competition

MetricAbingdon HealthDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£11.95M£52.53M£6.18B£2.61B
Dividend YieldN/A3.87%5.72%5.37%
P/E Ratio-8.450.8929.67400.16
Price / Sales1.75542.43579.4198,165.99
Price / Cash2.2511.4236.5527.90
Price / Book8.482.8412.077.36
Net Income-£796.37K£334.07B£3.32B£5.89B
7 Day Performance-3.14%7.22%0.64%0.71%
1 Month Performance8.25%1.92%5.17%0.95%
1 Year Performance-23.35%3.34%61.77%116.77%

Abingdon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABDX
Abingdon Health
N/AGBX 6.17
-1.3%
N/A-29.5%£11.95M£6.82M-8.4584
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
VRCI
Verici Dx
N/AGBX 0.84
-6.2%
N/A-78.5%£12.77M£1.91M-29.1019Gap Down
High Trading Volume
GENI
GENinCode
N/AGBX 3.29
-8.8%
N/A-3.1%£9.42M£2.91M-139.792,300Gap Up
GDR
genedrive
N/AGBX 0.60
+3.4%
N/A-78.1%£6.15M£676K-27.7843Gap Up
High Trading Volume
AGL
ANGLE
2.111 of 5 stars
GBX 1.80
+2.9%
GBX 40
+2,122.2%
-72.1%£5.81M£2.62M-37.50650Positive News
Gap Up
PRM
Proteome Sciences
N/AGBX 1.51
-22.4%
N/A-8.9%£4.46M£4.53M-133.63240Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.56
+3.7%
N/A+17.9%£3.23M£5.72B0.306,692
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-63.5%£1.16M£33.87K-0.2815Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:ABDX) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners